| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 26 | +61.54% | -1.04% | +1.68% | -2.71% | -7.61% | — |
| 14d | 26 | +57.69% | +0.81% | +0.69% | +0.11% | -11.85% | — |
| 30d | 26 | +57.69% | -0.26% | +5.23% | -5.49% | -15.13% | — |
| 60d | 26 | +57.69% | -7.04% | +8.19% | -15.24% | -27.61% | — |
| 90d | 26 | +50.00% | -6.39% | +10.41% | -16.80% | -27.51% | — |
| 180d | 26(1 pending) | +60.00% | +27.53% | +18.38% | +9.15% | -51.68% | — |
| 1y | 26(1 pending) | +60.00% | -4.52% | +31.29% | -35.81% | -91.44% | — |
| 2y | 26(1 pending) | +100.00% | -49.41% | +18.38% | -67.78% | -84.25% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ORKA ORUKA THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,729 | $69.69 | $120.5K | 925,580 | Jun 15, 2026 | Jun 15, 2026 ↗ | View → |
| JBIO JADE BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 34,843 | — | — | 34,843 | Jun 9, 2026 | Jun 11, 2026 ↗ | View → |
| ORKA ORUKA THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,729 | $41.30 | $71.4K | 927,309 | Mar 16, 2026 | Mar 17, 2026 ↗ | View → |
| ORKA ORUKA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 306,700 | — | — | 306,700 | Jan 23, 2026 | Jan 23, 2026 ↗ | View → |
| ORKA ORUKA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 76,700 | — | — | 929,038 | Jan 23, 2026 | Jan 23, 2026 ↗ | View → |
| JBIO JADE BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 23,017 | — | — | 23,017 | Apr 29, 2025 | May 1, 2025 ↗ | View → |
| ORKA ORUKA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 230,000 | — | — | 230,000 | Jan 22, 2025 | Jan 22, 2025 ↗ | View → |
| JSPR JASPER THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 47,000 | — | — | 47,000 | Jun 7, 2023 | Jun 8, 2023 ↗ | View → |
| JSPR JASPER THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 24,500 | — | — | 24,500 | Oct 12, 2022 | Oct 13, 2022 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 12,500 | — | — | 12,500 | Aug 16, 2022 | Aug 18, 2022 ↗ | View → |
| DYN DYNE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 7,222 | — | — | 7,222 | Jul 5, 2022 | Jul 6, 2022 ↗ | View → |
| DYN DYNE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,596 | — | — | 19,596 | Jun 3, 2022 | Jun 6, 2022 ↗ | View → |
| JSPR JASPER THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 78,045 | — | — | 78,045 | Mar 21, 2022 | Mar 23, 2022 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 1,229 | $61.08 | $75.1K | 26,797 | Mar 14, 2022 | Mar 14, 2022 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 1,883 | $62.56 | $117.8K | 25,026 | Mar 11, 2022 | Mar 14, 2022 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 3,000 | — | — | 9,000 | Mar 11, 2022 | Mar 14, 2022 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 3,000 | — | — | 28,026 | Mar 11, 2022 | Mar 14, 2022 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 4,584 | — | — | 4,583 | Mar 10, 2022 | Mar 14, 2022 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 4,584 | — | — | 26,909 | Mar 10, 2022 | Mar 14, 2022 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 20,400 | — | — | 20,400 | Feb 18, 2022 | Feb 22, 2022 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 46,200 | — | — | 46,200 | Feb 18, 2022 | Feb 22, 2022 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 11,185 | $69.17 | $773.7K | 22,325 | Dec 6, 2021 | Dec 7, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 26,667 | — | — | 33,510 | Dec 3, 2021 | Dec 7, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 26,667 | — | — | 13,333 | Dec 3, 2021 | Dec 7, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 13,800 | — | — | 13,800 | Oct 15, 2021 | Oct 18, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 4,207 | $117.86 | $495.8K | 6,843 | Sep 13, 2021 | Sep 14, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 10,000 | — | — | 0 | Sep 10, 2021 | Sep 14, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 10,000 | — | — | 11,050 | Sep 10, 2021 | Sep 14, 2021 ↗ | View → |
| DYN DYNE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,596 | — | — | 19,596 | May 26, 2021 | May 27, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 88,000 | $128.20 | $11.28M | 13,050 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 12,000 | $14.43 | $173.2K | 89,050 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 12,000 | — | — | 2,666 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 20,000 | $40.87 | $817.4K | 77,050 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 22,000 | $51.49 | $1.13M | 47,050 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 20,000 | — | — | 25,000 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 12,000 | $126.97 | $1.52M | 1,050 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 12,000 | — | — | 43,000 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 22,000 | — | — | 38,000 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 12,000 | — | — | 3,000 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 12,000 | $44.67 | $536.0K | 25,050 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 12,000 | $17.66 | $211.9K | 101,050 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 10,000 | — | — | 10,000 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 10,000 | $29.87 | $298.7K | 57,050 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 33,334 | — | — | 33,334 | Mar 11, 2021 | Mar 12, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 12,000 | — | — | 12,000 | Mar 11, 2021 | Mar 12, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 2,141 | $124.15 | $265.8K | 13,050 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 4,583 | — | — | 15,191 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 8,666 | $12.57 | $108.9K | 28,666 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 2 | $219.99 | $440 | 20,000 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 2,911 | $211.44 | $615.5K | 25,755 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 2,800 | $213.64 | $598.2K | 32,900 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 1,200 | $213.71 | $256.5K | 22,000 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 1,400 | $214.46 | $300.2K | 20,600 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 1,500 | $216.39 | $324.6K | 30,700 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 8,666 | — | — | 0 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 9,997 | $217.42 | $2.17M | 20,703 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 200 | $217.45 | $43.5K | 20,000 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 16,334 | — | — | 14,666 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 701 | $218.54 | $153.2K | 20,002 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 2,555 | $212.54 | $543.0K | 23,200 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 400 | $216.24 | $86.5K | 20,200 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 700 | $214.60 | $150.2K | 32,200 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 634 | $212.20 | $134.5K | 35,700 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 16,344 | $14.43 | $235.8K | 36,334 | Jan 15, 2021 | Jan 20, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 16,334 | $14.43 | $235.7K | 26,942 | Jan 15, 2021 | Mar 12, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 9,392 | $153.11 | $1.44M | 10,608 | Jan 2, 2021 | Jan 4, 2021 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 16,666 | — | — | 16,666 | Oct 5, 2020 | Oct 6, 2020 ↗ | View → |
| DYN DYNE THERAPEUTICS, INC. | PURCHASE | 10,725 | — | — | 10,725 | Sep 21, 2020 | Sep 23, 2020 ↗ | View → |
| DYN DYNE THERAPEUTICS, INC. | SALE | 35,574 | — | — | 0 | Sep 21, 2020 | Sep 23, 2020 ↗ | View → |
| DYN DYNE THERAPEUTICS, INC. | PURCHASE | 35,574 | $2.81 | $100.0K | 35,574 | Aug 7, 2020 | Sep 23, 2020 ↗ | View → |
| DYN DYNE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 11,156 | — | — | 11,156 | Jul 31, 2020 | Sep 23, 2020 ↗ | View → |
| DYN DYNE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 14,444 | — | — | 14,444 | Jul 31, 2020 | Sep 23, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 4,912 | $12.57 | $61.7K | 24,912 | Jun 25, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 4,912 | $75.18 | $369.3K | 20,000 | Jun 25, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 4,912 | — | — | 8,666 | Jun 25, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 6,600 | $74.90 | $494.3K | 39,822 | Jun 24, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 26,422 | — | — | 13,578 | Jun 24, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 38,666 | — | — | 0 | Jun 24, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 38,666 | $5.86 | $226.6K | 58,666 | Jun 24, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 26,422 | $12.57 | $332.1K | 46,422 | Jun 24, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 22,700 | $76.50 | $1.74M | 20,000 | Jun 24, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 800 | $76.50 | $61.2K | 35,088 | Jun 24, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 15,966 | $75.93 | $1.21M | 42,700 | Jun 24, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 2,913 | $76.26 | $222.1K | 20,000 | Jun 24, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 12,175 | $75.32 | $917.1K | 22,913 | Jun 24, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 3,934 | $75.94 | $298.7K | 35,888 | Jun 24, 2020 | Jun 26, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 24,318 | $60.38 | $1.47M | 20,682 | May 11, 2020 | May 13, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASE CBO & COO | 25,000 | $5.86 | $146.5K | 45,000 | May 11, 2020 | May 13, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 682 | $61.07 | $41.6K | 20,000 | May 11, 2020 | May 13, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | SALE CBO & COO | 25,000 | — | — | 38,666 | May 11, 2020 | May 13, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 55,000 | — | — | 55,000 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 13,750 | — | — | 13,750 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |